Kyntra Bio, Inc.
KYNB
$7.91
-$0.13-1.65%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 11.97M | -15.20M | -14.22M | 200.64M | -7.60M |
| Total Depreciation and Amortization | 6.00K | 7.00K | 8.00K | 192.00K | 221.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -30.05M | 1.03M | 726.00K | -42.35M | 2.27M |
| Change in Net Operating Assets | 14.08M | 270.00K | -4.84M | -160.33M | 17.79M |
| Cash from Operations | -3.99M | -13.89M | -18.33M | -1.85M | 12.68M |
| Capital Expenditure | -- | -- | 0.00 | -9.00K | -13.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 3.99M | -60.00K | 6.41M | 90.20M | -- |
| Other Investing Activities | 13.68M | 3.08M | -58.12M | -3.04M | -- |
| Cash from Investing | 17.67M | 3.02M | -51.71M | 87.16M | -13.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -6.00K | -80.55M | 3.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -5.00K | -7.00K | -8.00K | -12.00K | -12.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -5.35M | 0.00 |
| Cash from Financing | -5.00K | -7.00K | -14.00K | -85.92M | -9.00K |
| Foreign Exchange rate Adjustments | -30.00K | 1.00K | -49.00K | -1.26M | 981.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.65M | -10.88M | -70.10M | -1.87M | 13.64M |